Bone marrow fibrosis as a feature of systemic lupus erythematosus: A case report and literature review

SpringerPlus

Volumn 3, Issue 1, 2014, Pages 1-10

  Chalayer, Émilie ^a   Ffrench, Martine ^b   Cathébras, Pascal ^a  

^a HÔPITAL NORD   (France)

^b CENTRE HOSPITALIER LYON SUD   (France)

Author keywords

Bone marrow; Primary myelofibrosis; Systemic lupus erythematosus

Indexed keywords

EID: 84938279276     PISSN: None     EISSN: 21931801     Source Type: Journal    
DOI: 10.1186/2193-1801-3-349     Document Type: Review

References (33)

1. Agarwal BR, Bhalla K, Dalvi R, Currimbhoy ZE, Mehta KP: Myelofibrosis secondary to SLE and its reversal on steroid therapy. Indian Pediatr 1995, 32: 1207-1210.
2. Aharon A, Levy Y, Bar-Dayan Y, Afek A, Zandman-Goddard G, Skurnik Y, Fabrrizzi F, Shoenfeld Y: Successful treatment of early secondary myelofibrosis in SLE with IVIG. Lupus 1997, 6: 408-411. doi: 10. 1177/096120339700600412 10. 1177/096120339700600412.
3. Amital H, Rewald E, Levy Y, Bar-Dayan Y, Manthorpe R, Engervall P, Sherer Y, Langevitz P, Shoenfeld Y: Fibrosis regression induced by intravenous gammaglobulin treatment. Ann Rheum Dis 2003, 62: 175-177. doi: 10. 1136/ard. 62. 2. 175 10. 1136/ard. 62. 2. 175.
4. Aziz AR, Ashraf R, Mohammadian Y, Ruby C, Momin Z, Kumar A, Griciene P, Gintautas J: Systemic lupus erythematosus presenting with pancytopenia due to bone marrow myelofibrosis in a 22-year-old male. Clin Adv Hematol Oncol 2004, 2: 467-469. discussion 469-470.
5. Bass RD, Randall D, Pullarkat V, Feinstein DI, Kaul A, Winberg CD, Brynes RK: Pathology of autoimmune myelofibrosis a report of three cases and a review of the literature. Am J Clin Pathol 2001, 116: 211-216. 10. 1309/6Q99-VRNL-7BTP-W1G8.
6. Beyan E, Beyan C, Turan M: Hematological presentation in systemic lupus erythematosus and its relationship with disease activity. Hematology 2007, 12: 257-261. doi: 10. 1080/10245330701214145 10. 1080/10245330701214145.
7. Borba EF, Pereira RM, Velloso ED, Pereira IA, Goncalves CR, Yoshinari NH: Neutropenia associated with myelofibrosis in systemic lupus erythematosus. Acta Haematol 1993, 89: 82-85. 10. 1159/000204493.
8. Cavalcant J, Shadduck RK, Winkeistein A, Zeigler Z, Mendelow H: Red-cell hypoplasia and increased bone marrow reticulin in systemic lupus erythematosis: Reversal with corticosteroid therapy. Am J Hematol 1978, 5: 253-263. 10. 1002/ajh. 2830050310.
9. Daly HM, Scott GL: Myelofibrosis as a cause of pancytopenia in systemic lupus erythematosus. J Clin Pathol 1983, 36: 1219-1222. doi: 10. 1136/jcp. 36. 11. 1219 10. 1136/jcp. 36. 11. 1219.
10. Durupt S, David G, Durieu I, Nove-Josserand R, Vital DD: Myelofibrosis in systemic lupus erythematosus: a new case. Eur J Intern Med 2000, 11: 98-100. 10. 1016/S0953-6205(00)00064-9.
11. El Mouzan MI, Ahmad MA, al Fadel Saleh M, al Sohaibani MO, al Gindan YM: Myelofibrosis and pancytopenia in systemic lupus erythematosus. Acta Haematol 1988, 80: 219-221. 10. 1159/000205641.
12. Foley-Nolan D, Martin MF, Rowbotham D, McVerry A, Gooi HC: Systemic lupus erythematosus presenting with myelofibrosis. J Rheumatol 1992, 19: 1303-1304.
13. Gernsheimer T: Chronic idiopathic thrombocytopenic purpura: mechanisms of pathogenesis. Oncologist 2009, 14: 12-21. doi: 10. 1634/theoncologist. 2008-0132 10. 1634/theoncologist. 2008-0132.
14. Hepburn AL, Lampert IA, Boyle JJ, Horncastle D, Fai Ng W, Layton M, Vyse TJ, Botto M, Mason JC: In vivo evidence for apoptosis in the bone marrow in systemic lupus erythematosus. Ann Rheum Dis 2007, 66: 1106-1109. doi: 10. 1136/ard. 2006. 065003 10. 1136/ard. 2006. 065003.
15. Hirose W, Fukuya H, Anzai T, Kawagoe M, Kawai T, Watanabe K: Myelofibrosis and systemic lupus erythematosus. J Rheumatol 1993, 20: 2164-2166.
16. Hochberg MC: Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997, 40: 1725-1734. doi: 10. 1002/1529-0131(199709)40: 9<1725:: AID-ART29>3. 0. CO;2-Y.
17. Inoue Y, Matsubara A, Okuya S, Okafuji K, Kaku K, Kaneko T: Myelofibrosis and systemic lupus erythematosus: reversal of fibrosis with high-dose corticosteroid therapy. Acta Haematol 1992, 88: 32-36. 10. 1159/000204592.
18. Kaelin WG, Spivak JL: Systemic lupus erythematosus and myelofibrosis. Am J Med 1986, 81: 935-938. 10. 1016/0002-9343(86)90373-6.
19. Kiss E, Gaal IA, Simkovics EO, Kiss A: Myelofibrosis in systemic lupus erythematosus. Leuk Lymphoma 2000, 39: 661-665. 10. 3109/10428190009113399.
20. Kuter DJ, Bain B, Mufti G, Bagg A, Hasserjian RP: Bone marrow fibrosis: pathophysiology and clinical significance of increased bone marrow stromal fibres. Br J Haematol 2007, 139: 351-362. 10. 1111/j. 1365-2141. 2007. 06807. x.
21. Le Bousse-Kerdilès M-C, Martyré M-C, Samson M: Cellular and molecular mechanisms underlying bone marrow and liver fibrosis: a review. Eur Cytokine Netw 2008, 19: 69-80.
22. Matsouka C, Liouris J, Andrianakos A, Papademetriou C, Karvountzis G: Systemic lupus erythematosus and myelofibrosis. Clin Rheumatol 1989, 8: 402-407. 10. 1007/BF02030356.
23. Nanji AA, Jetha N: Myelofibrosis as a cause of pancytopenia in systemic lupus erythematosus. J Clin Pathol 1984, 37: 714. doi: 10. 1136/jcp. 37. 6. 714-a.
24. Paquette RL, Meshkinpour A, Rosen PJ: Autoimmune myelofibrosis. A steroid-responsive cause of bone marrow fibrosis associated with systemic lupus erythematosus. Medicine (Baltimore) 1994, 73: 145-152.
25. Pereira RMR, Velloso ERP, Menezes Y, Gualandro S, Vassalo J, Yoshinari NH: Bone marrow findings in systemic lupus erythematosus patients with peripheral cytopenias. Clin Rheumatol 1998, 17: 219-222. 10. 1007/BF01451051.
26. Pillai A, Gautam M, Williamson H, Martlew V, Nash J, Thachil J: Multisystem failure due to three coexisting autoimmune diseases. Intern Med 2009, 48: 837-842. 10. 2169/internalmedicine. 48. 1957.
27. Pullarkat V, Bass RD, Gong JZ, Feinstein DI, Brynes RK: Primary autoimmune myelofibrosis: Definition of a distinct clinicopathologic syndrome. Am J Hematol 2003, 72: 8-12. doi: 10. 1002/ajh. 10258 10. 1002/ajh. 10258.
28. Ramakrishna R, Kyle PW, Day PJ, Manoharan A: Evans' syndrome, myelofibrosis and systemic lupus erythematosus: role of procollagens in myelofibrosis. Pathology 1995, 27: 255-259. 10. 1080/00313029500169073.
29. Sacre K, Aguilar C, Deligny C, Choudat L, Koch P, Arfi S, Papo T: Lytic bone lesions in lupus-associated myelofibrosis. Lupus 2009, 19: 313-316. doi: 10. 1177/0961203309349118.
30. Sarkar RN, Banerjee S, Dey S, Saha A, Bhattacharjee P, Banerjee TK, Sinha PK, Chakraborty A: Haematological presentation of systemic lupus erythematosus. J Assoc Physicians India 2009, 57: 767-768.
31. Tefferi A, Lasho TL, Jimma T, Finke CM, Gangat N, Vaidya R, Begna KH: One Thousand Patients With Primary Myelofibrosis: The Mayo Clinic Experience. Mayo Clin Proc 2012, 87: 25-33. doi: 10. 1016/j. mayocp. 2011. 11. 001 10. 1016/j. mayocp. 2011. 11. 001.
32. Thiele J, Kvasnicka HM: Grade of bone marrow fibrosis is associated with relevant hematological findings-a clinicopathological study on 865 patients with chronic idiopathic myelofibrosis. Ann Hematol 2006, 85: 226-232. doi: 10. 1007/s00277-005-0042-8 10. 1007/s00277-005-0042-8.
33. Vora BJ, Byers RJ, Lucas GS, Gokal R: Reversal of osteomyelosclerosis-associated systemic lupus nephritis. Nephrol Dial Transplant 1998, 13: 1559-1561. doi: 10. 1093/ndt/13. 6. 1559 10. 1093/ndt/13. 6. 1559.